Application

17892833 · ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES

Filed 2022-08-22 · Abandoned The official file ↗ · Art unit 1628 · Examiner Theodore R Howell Typical · CPC A61K 9/0095 · ObsEva S.A. · Clark+Elbing LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

25.1 mo

to disposition 37.5 mo

Statutes raised

102 103 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.